Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Apremilast (Primary) ; Tumour necrosis factor alpha inhibitors
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms CATARA
- 11 Dec 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 27 Sep 2010 New trial record